Market Overview:
The global antimicrobial therapeutics market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, rising demand for novel antibiotics, and growing awareness about the benefits of antimicrobial therapies. The hospital segment is expected to dominate the global antimicrobial therapeutics market in terms of revenue by 2030. This can be attributed to the increasing number of hospital-acquired infections (HAIs) and rising demand for novel antibiotics in hospitals. The clinic segment is projected to grow at a higher CAGR than other segments during the forecast period owing to factors such as growing prevalence of antibiotic-resistant infections and increase in outpatient visits across regions. In terms of application, antiviral drugs are expected to account for the largest share of revenue by 2030 owing high adoption rates across regions coupled with rising incidences viral diseases such as HIV/AIDS, hepatitis B &C, herpes simplex virus (HSV), and varicella zoster virus (VZV).
Product Definition:
Antimicrobial therapeutics is a medical specialty that deals with the treatment of infections using drugs. Antimicrobial therapy is important because it can prevent or treat serious infections, which can lead to death in some cases.
Hospital:
Hospital is an environment where patients are admitted for a short duration for treatment of acute injury, disease or sickness. The growth factor in antimicrobial therapeutics market is increasing the demand and supply of hospital services globally. Hospital’s role in the management of infectious diseases has been changing over time due to advancements in technology and changes in lifestyle which has led to rise incidences of infections worldwide.
Clinic:
Clinics are medical facilities that provide primary care to the patients. The main aim of these facilities is to help patients achieve better health through prevention and diagnosis of diseases. These medical facilities may also include surgical services, X-ray, laboratory tests and other ancillary services but their major service is providing primary care. Antimicrobial therapeutics market includes products used for treatment against infections by microorganisms such as bacteria, viruses or fungi.
Application Insights:
The antimicrobial therapeutics market is categorized based on application into antiviral, antibacterial, antifungal, and antiparasitic. The antibacterial segment dominated the global market in 2017 owing to the rising prevalence of infectious diseases such as tuberculosis and skin infections. In addition, increasing healthcare spending by countries such as China and India will boost product demand over the forecast period.
The antiviral segment is expected to witness lucrative growth during the forecast period due to rapid advancements in drug development against HIV/AIDS along with other viral infections including hepatitis C virus (HCV). For instance, according to UNAIDS Report 2016 there were 37 million people living with HIV across Africa; out of which 19 million were women.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to continue its dominance over the forecast period. The region accounts for a large share of the overall population, which makes it susceptible to various infectious diseases. Moreover, increasing disposable income levels and rising healthcare expenditure are anticipated to drive growth during the forecast period.
The Asia Pacific market is also characterized by rapidly growing economies such as China and India that have a high potential for growth in terms of antimicrobial consumption rates owing to factors such as rising prevalence of infectious diseases, improving living standards & economic development along with an increase in healthcare spending capacity among individuals & governments at both domestic and regional levels.
In addition, favorable government initiatives pertaining toward increasing access towards treatment options are further expected to fuel demand across this region during the forecast period.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the antimicrobial therapeutics market. According to the World Health Organization (WHO), every year around 2 million people die due to infections, and this number is estimated to increase in future. This will create a high demand for antimicrobial drugs and therapies, thereby driving the growth of the antimicrobial therapeutics market.
- Rising prevalence of multidrug-resistant bacteria: The rising prevalence of multidrug-resistant bacteria is another major factor that is expected to drive the growth of the antimicrobial therapeutics market in future. Multidrug-resistant bacteria are resistant to a wide range of antibiotics, which makes them difficult to treat. This increases the need for novel and more effective antibiotics, which will create a high demand for antimicrobial drugs and therapies, thereby propellingthe growthof thismarket segment .
Scope Of The Report
Report Attributes
Report Details
Report Title
Antimicrobial Therapeutics Market Research Report
By Type
Hospital, Clinic, Personal, Other
By Application
Antiviral, Antibacterial, Antifungal, Antiparasitic
By Companies
Gilead Sciences, Inc., GlaxoSmithKline plc, Merck & Co Inc., Pfizer Inc., Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
138
Number of Tables & Figures
97
Customization Available
Yes, the report can be customized as per your need.
Global Antimicrobial Therapeutics Market Report Segments:
The global Antimicrobial Therapeutics market is segmented on the basis of:
Types
Hospital, Clinic, Personal, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antiviral, Antibacterial, Antifungal, Antiparasitic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Gilead Sciences, Inc.
- GlaxoSmithKline plc
- Merck & Co Inc.
- Pfizer Inc.
- Sanofi
Highlights of The Antimicrobial Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hospital
- Clinic
- Personal
- Other
- By Application:
- Antiviral
- Antibacterial
- Antifungal
- Antiparasitic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antimicrobial Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antimicrobial therapeutics are medications that are used to treat infections. These medications work by killing or preventing the growth of bacteria.
Some of the major companies in the antimicrobial therapeutics market are Gilead Sciences, Inc., GlaxoSmithKline plc, Merck & Co Inc., Pfizer Inc., Sanofi.
The antimicrobial therapeutics market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antimicrobial Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antimicrobial Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antimicrobial Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antimicrobial Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antimicrobial Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Antimicrobial Therapeutics Market Size and Y-o-Y Growth
4.5.2 Antimicrobial Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Antimicrobial Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Antimicrobial Therapeutics Market Size Forecast by Type
5.2.1 Hospital
5.2.2 Clinic
5.2.3 Personal
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Antimicrobial Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Antimicrobial Therapeutics Market Size Forecast by Applications
6.2.1 Antiviral
6.2.2 Antibacterial
6.2.3 Antifungal
6.2.4 Antiparasitic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antimicrobial Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antimicrobial Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Antimicrobial Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Antimicrobial Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Antimicrobial Therapeutics Market Size Forecast by Type
9.6.1 Hospital
9.6.2 Clinic
9.6.3 Personal
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Antimicrobial Therapeutics Market Size Forecast by Applications
9.10.1 Antiviral
9.10.2 Antibacterial
9.10.3 Antifungal
9.10.4 Antiparasitic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Antimicrobial Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Antimicrobial Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Antimicrobial Therapeutics Market Size Forecast by Type
10.6.1 Hospital
10.6.2 Clinic
10.6.3 Personal
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Antimicrobial Therapeutics Market Size Forecast by Applications
10.10.1 Antiviral
10.10.2 Antibacterial
10.10.3 Antifungal
10.10.4 Antiparasitic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Antimicrobial Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Antimicrobial Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Antimicrobial Therapeutics Market Size Forecast by Type
11.6.1 Hospital
11.6.2 Clinic
11.6.3 Personal
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Antimicrobial Therapeutics Market Size Forecast by Applications
11.10.1 Antiviral
11.10.2 Antibacterial
11.10.3 Antifungal
11.10.4 Antiparasitic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Antimicrobial Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Antimicrobial Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Antimicrobial Therapeutics Market Size Forecast by Type
12.6.1 Hospital
12.6.2 Clinic
12.6.3 Personal
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Antimicrobial Therapeutics Market Size Forecast by Applications
12.10.1 Antiviral
12.10.2 Antibacterial
12.10.3 Antifungal
12.10.4 Antiparasitic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Antimicrobial Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Antimicrobial Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Antimicrobial Therapeutics Market Size Forecast by Type
13.6.1 Hospital
13.6.2 Clinic
13.6.3 Personal
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Antimicrobial Therapeutics Market Size Forecast by Applications
13.10.1 Antiviral
13.10.2 Antibacterial
13.10.3 Antifungal
13.10.4 Antiparasitic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antimicrobial Therapeutics Market: Competitive Dashboard
14.2 Global Antimicrobial Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Gilead Sciences, Inc.
14.3.2 GlaxoSmithKline plc
14.3.3 Merck & Co Inc.
14.3.4 Pfizer Inc.
14.3.5 Sanofi
